These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37948046)

  • 41. Microdosing, imaging biomarkers and SPECT: a multi-sided tripod to accelerate drug development.
    Pauwels EK; Bergstrom K; Mariani G; Kairemo K
    Curr Pharm Des; 2009; 15(9):928-34. PubMed ID: 19275656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radioligand development for molecular imaging of the central nervous system with positron emission tomography.
    Honer M; Gobbi L; Martarello L; Comley RA
    Drug Discov Today; 2014 Dec; 19(12):1936-44. PubMed ID: 25173703
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Vidal B; Fieux S; Colom M; Billard T; Bouillot C; Barret O; Constantinescu C; Tamagnan G; Newman-Tancredi A; Zimmer L
    Brain Struct Funct; 2018 Jul; 223(6):2973-2988. PubMed ID: 29730825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting brain concentrations of drug using positron emission tomography and venous input: modeling of arterial-venous concentration differences.
    Syvänen S; Blomquist G; Appel L; Hammarlund-Udenaes M; Långström B; Bergström M
    Eur J Clin Pharmacol; 2006 Oct; 62(10):839-48. PubMed ID: 16896783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hybrid PET-MRI Applications in Movement Disorders.
    Tondo G; Esposito M; Dervenoulas G; Wilson H; Politis M; Pagano G
    Int Rev Neurobiol; 2019; 144():211-257. PubMed ID: 30638455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiochemistry: A Useful Tool in the Ophthalmic Drug Discovery.
    Pulagam KR; Gómez-Vallejo V; Llop J; Rejc L
    Curr Med Chem; 2020; 27(4):501-522. PubMed ID: 31142249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imaging Histamine H3 Receptors with Positron Emission Tomography.
    Rusjan PM; Le Foll B
    Curr Top Behav Neurosci; 2022; 59():147-167. PubMed ID: 34964937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RO6807936 as a novel positron emission tomography (PET) radiotracer for in vitro and in vivo visualization and quantification of beta-site amyloid precursor protein cleaving enzyme (BACE1) in the rodent and baboon brain.
    Honer M; Polara A; Kuwabara H; Jacobsen H; Pähler A; Hartung T; Caruso A; Esterhazy D; Stoffel M; Dannals RF; Wong DF; Borroni E; Gobbi LC
    J Labelled Comp Radiopharm; 2023 Jul; 66(9):222-236. PubMed ID: 37095603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional Characterization of 5-HT
    Hansen HD; Mandeville JB; Sander CY; Hooker JM; Catana C; Rosen BR; Knudsen GM
    J Neurosci; 2017 Nov; 37(44):10671-10678. PubMed ID: 28972127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances in Drug Discovery and Development in Geriatric Psychiatry.
    C Conley A; A Newhouse P
    Curr Psychiatry Rep; 2018 Mar; 20(2):10. PubMed ID: 29504046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The diminished pipeline for medications to treat mental health and substance use disorders.
    O'Brien PL; Thomas CP; Hodgkin D; Levit KR; Mark TL
    Psychiatr Serv; 2014 Dec; 65(12):1433-8. PubMed ID: 25178309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Translational Model-Informed Dose Selection for a Human Positron Emission Tomography Imaging Study of JNJ-54175446, a P2X7 Receptor Antagonist.
    Xu Y; Miao X; Ravenstijn P; Hijzen A; Schmidt ME; Nandy P; Zhou H
    Clin Transl Sci; 2020 Mar; 13(2):309-317. PubMed ID: 31642608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pre-clinical characterization of [11C]R05013853 as a novel radiotracer for imaging of the glycine transporter type 1 by positron emission tomography.
    Borroni E; Zhou Y; Ostrowitzki S; Alberati D; Kumar A; Hainzl D; Hartung T; Hilton J; Dannals RF; Wong DF
    Neuroimage; 2013 Jul; 75():291-300. PubMed ID: 22178811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of positron emission tomography in the discovery and development of new drugs; as studied in laboratory animals.
    Roselt P; Meikle S; Kassiou M
    Eur J Drug Metab Pharmacokinet; 2004; 29(1):1-6. PubMed ID: 15151164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Opportunities in precision psychiatry using PET neuroimaging in psychosis.
    Coughlin JM; Horti AG; Pomper MG
    Neurobiol Dis; 2019 Nov; 131():104428. PubMed ID: 30904669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How to design PET experiments to study neurochemistry: application to alcoholism.
    Morris ED; Lucas MV; Petrulli JR; Cosgrove KP
    Yale J Biol Med; 2014 Mar; 87(1):33-54. PubMed ID: 24600335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Positron Emission Tomography (PET) for Molecular Plant Imaging.
    Komarov S; Tai YC
    Methods Mol Biol; 2022; 2539():97-118. PubMed ID: 35895200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter.
    Saijo T; Maeda J; Okauchi T; Maeda J; Morio Y; Kuwahara Y; Suzuki M; Goto N; Suzuki K; Higuchi M; Suhara T
    Int J Neuropsychopharmacol; 2009 Sep; 12(8):1021-32. PubMed ID: 19236731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Positron emission tomography for use in microdosing studies.
    Wagner CC; Müller M; Lappin G; Langer O
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluorination methods for drug discovery and development.
    Richardson P
    Expert Opin Drug Discov; 2016 Oct; 11(10):983-99. PubMed ID: 27548817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.